Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2013 May 21;8(5):e64549.
doi: 10.1371/journal.pone.0064549. Print 2013.

Eplerenone attenuates pulse wave reflection in chronic kidney disease stage 3-4--a randomized controlled study

Lene Boesby  1 , Thomas Elung-Jensen, Svend Strandgaard, Anne-Lise Kamper
Affiliations
Randomized Controlled Trial

Eplerenone attenuates pulse wave reflection in chronic kidney disease stage 3-4--a randomized controlled study

Lene Boesby et al. PLoS One. .

Abstract

Background: Patients with chronic kidney disease (CKD) have high cardiovascular mortality and morbidity associated with increased arterial stiffness. Plasma aldosterone levels are increased in CKD, and aldosterone has been found to increase vascular inflammation and fibrosis. It was hypothesized that aldosterone receptor inhibition with eplerenone could reduce arterial stiffness in CKD stage 3-4.

Study design: The design was randomized, open, parallel group. Measurements of arterial stiffness markers were undertaken at weeks 1 and 24.

Intervention: 24 weeks of add-on treatment with 25-50 mg eplerenone or standard medication.

Outcomes: Primary outcome parameter was carotid-femoral pulse wave velocity (cfPWV). Secondary outcomes were augmentation index (AIx), ambulatory arterial stiffness index (AASI) and urinary albumin excretion.

Results: Fifty-four CKD patients (mean eGFR 36 mL/min/1.73 m(2), SD 11) were randomized. Forty-six patients completed the trial. The mean difference in cfPWV changes between groups was 0.1 m/s (95%CI: -1.0, 1.3), P = 0.8. The mean difference in AIx changes between groups was 4.4% (0.1, 8.6), P = 0.04. AASI was unchanged in both groups. The ratio of change in urinary albumin excretion in the eplerenone group compared to the control was 0.61 (0.37, 1.01), P = 0.05. Four patients were withdrawn from the eplerenone group including three because of possible side effects; one was withdrawn from the control group. Mild hyperkalemia was seen on three occasions and was easily managed.

Limitations: The full planned number of patients was not attained. The duration of the trial may have been too short to obtain full effect of eplerenone on the arteries.

Conclusions: Add-on treatment with eplerenone in CKD stage 3-4 did not significantly reduce cfPWV. There may be beneficial vascular effects leading to attenuated pulse wave reflection. Treatment was well-tolerated.

Trial registration: ClinicalTrials.govNCT01100203.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. CONSORT FLOW DIAGRAM showing recruitment of patients and flow through study.
See this image and copyright information in PMC

References

    1. Mourad JJ, Pannier B, Blacher J, Rudnichi A, Benetos A, et al. (2001) Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. Kidney Int 59 (5) 1834–1841. - PubMed
    1. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, et al. (2001) Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 103 (7) 987–992. - PubMed
    1. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, et al. (1999) Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99 (18) 2434–2439. - PubMed
    1. Li Y, Dolan E, Wang JG, Thijs L, Zhu DL, et al. (2006) Ambulatory arterial stiffness index: determinants and outcome. Blood Press Monit 11 (2) 107–110. - PubMed
    1. Hansen TW, Li Y, Staessen JA, Jeppesen J, Rasmussen S, et al. (2008) Independent prognostic value of the ambulatory arterial stiffness index and aortic pulse wave velocity in a general population. J Hum Hypertens 22 (3) 214–216. - PubMed

Publication types

MeSH terms

Associated data